Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza
Alcon Inc. Ordinary Shares (ALC)
Last alcon inc. ordinary shares earnings: 2/25 04:30 pm
Check Earnings Report
Company Research
Source: Business Wire
Expands Alcon’s existing portfolio and strengthens position in the ophthalmic eye drops marketBuilds on company’s ophthalmic pharmaceutical manufacturing expertise GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has signed an agreement to acquire exclusive U.S. commercialization rights to Simbrinza®(brinzolamide/brimonidine tartrate ophthalmic suspension) 1%/0.2% from Novartis.The acquisition of Simbrinza combined with the company’s existing over-the-counter (OTC) eye drops will give Alcon a strong ophthalmic eye drop portfolio and the opportunity to capitalize on both the large glaucoma market and the fast-growing dry eye preservative free and eye allergy markets. The company’s strong U.S. ophthalmology expertise and existing relationships with healthcare professionals (HCP) will help drive HCP and patient adoption.Simbrinza is a fixed combination of a carbonic anhydrase inhibitor and an
Show less
Read more
Impact Snapshot
Event Time:
ALC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALC alerts
High impacting Alcon Inc. Ordinary Shares news events
Weekly update
A roundup of the hottest topics
ALC
News
- Alcon Publishes Agenda for 2024 Annual General Meeting [Yahoo! Finance]Yahoo! Finance
- Alcon Publishes Agenda for 2024 Annual General MeetingBusiness Wire
- Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India [Yahoo! Finance]Yahoo! Finance
- Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in IndiaBusiness Wire
- Vivity, the World's Leading EDOF IOL, Reaches One Million Milestone [Yahoo! Finance]Yahoo! Finance
ALC
Sec Filings
- 4/8/24 - Form 6-K
- 3/1/24 - Form 144
- 2/29/24 - Form 144
- ALC's page on the SEC website